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Background: Bovine leukemia virus (BLV) is associated with enzootic bovine leukosis (EBL), which is the most common
neoplastic disease of cattle. BLV infection may remain clinically silent at the aleukemic (AL) stage, cause persistent
lymphocytosis (PL), or, more rarely, B cell lymphoma. BLV has been identified in B cells, CD2+ T cells, CD3+ T cells,
CD4+ T cells, CD8+ T cells, γ/δ T cells, monocytes, and granulocytes in infected cattle that do not have tumors,
although the most consistently infected cell is the CD5+ B cell. The mechanism by which BLV causes uncontrolled
CD5+ B cell proliferation is unknown. Recently, we developed a new quantitative real-time polymerase chain
reaction (PCR) method, BLV-CoCoMo-qPCR, which enabled us to demonstrate that the proviral load correlates not
only with BLV infection, as assessed by syncytium formation, but also with BLV disease progression. The present
study reports the distribution of BLV provirus in peripheral blood mononuclear cell subpopulations isolated from
BLV-infected cows at the subclinical stage of EBL as examined by cell sorting and BLV-CoCoMo-qPCR.
Results: Phenotypic characterization of five BLV-infected but clinically normal cattle with a proviral load of > 100
copies per 1 × 105 cells identified a high percentage of CD5+ IgM+ cells (but not CD5- IgM+ B cells, CD4+ T cells, or
CD8+T cells). These lymphocyte subpopulations were purified from three out of five cattle by cell sorting or using
magnetic beads, and the BLV proviral load was estimated using BLV-CoCoMo-qPCR. The CD5+ IgM+ B cell
population in all animals harbored a higher BLV proviral load than the other cell populations. The copy number of
proviruses infecting CD5- IgM+ B cells, CD4+ cells, and CD8+ T cells (per 1 ml of blood) was 1/34 to 1/4, 1/22 to 1/3,
and 1/31 to 1/3, respectively, compared with that in CD5+ IgM+ B cells. Moreover, the BLV provirus remained integrated
into the genomic DNA of CD5+ IgM+ B cells, CD5- IgM+ B cells, CD4+ T cells, and CD8+ T cells, even in BLV-infected
cattle with a proviral load of <100 copies per 105 cells.
Conclusions: The results of the recent study showed that, although CD5+ IgM+ B cells were the main cell type
targeted in BLV-infected but clinically normal cattle, CD5- IgM+ B cells, CD4+ cells, and CD8+ T cells were infected to a
greater extent than previously thought.
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Bovine leukemia virus (BLV), a close relative of human
T cell leukemia virus types-1 and -2 (HTLV-1 and
HTLV-2), is the etiologic agent responsible for enzootic
bovine leukosis (EBL), which is the most common neo-
plastic disease of cattle. Infection by BLV may remain
clinically silent at the aleukemic (AL) stage. However, in
30% of infected cattle the infection may manifest as per-
sistent lymphocytosis (PL; a condition characterized by an
increase in the number of B lymphocytes), and in around
1–5% of cases it may manifest as B cell lymphoma after a
long period of latency [1]. Sheep experimentally inoculated
with BLV develop B cell tumors at a higher frequency
than naturally infected cattle, and the period of latency
is shorter [2,3].
In infected cattle with no evident tumor, BLV has been
identified in B cells, CD2+ T cells, CD3+ T cells, CD4+ T
cells, CD8+ T cells, γ/δ T cells, monocytes and granulocytes
[4-6]. By contrast, the increase in lymphocyte numbers
observed in cows with PL is entirely attributable to the
expansion of the CD5- and CD5+ B cell subpopulations,
indicating that CD5- and CD5+ B cells are the only
mononuclear cells within the peripheral blood that are
significantly infected with BLV [5]. Furthermore, the
most consistent tumor cell phenotypes isolated from
cattle with EBL are CD5+, CD6–, B1 low+, B2+, major
histocompatibility complex class II+, and either sIgM+ or
sIgM–; this indicates the involvement of the CD5+ B cell
sub population rather than the CD5-B cell sub popula-
tion. However, the mechanism by which BLV induces
uncontrolled CD5+ B cell proliferation is unknown. It is
interesting to note that in sheep, transformed B cells
show a CD5- phenotype [7]. Indeed, we previously
showed that the extended survival of peripheral blood
mononuclear cells (PBMCs) ex vivo was mainly due to
the presence of BLV-expressing CD5– B cells, indicating
that sheep CD5– B cells may be particularly susceptibi-
lity to the transforming effects of BLV [8]. This increase
in the survival of BLV-expressing sheep PBMCs was also
associated with an increase in the expression of mRNA
for bcl-xl, but not that for bcl-2 or bax [9]. However, the
mechanism by which BLV protects ex vivo cultured cells
against apoptosis is unknown.
After infecting cattle, BLV enters a period of latency,
during which expression is blocked at the transcriptional
level [10-12]. BLV-infected cattle retain at least one copy
of the full-length proviral genome throughout the course
of the disease [13], suggesting that the BLV provirus re-
mains integrated within the cellular genome [10], even in
the absence of detectable BLV antibodies [14]. Therefore,
diagnostic BLV polymerase chain reaction (PCR) tech-
niques, which detect the integrated BLV proviral genome
within the host genome, are now commonly used to
detect BLV infection in addition to routine diagnostic testssuch as agar gel immunodiffusion and enzyme-linked
immunosorbent assays (ELISAs) [13,15-18]. Recently,
we developed a new quantitative real-time PCR method
using Coordination of Common Motifs (CoCoMo)
primers to measure the proviral load of both known
and novel BLV variants in BLV-infected animals [14,19].
The assay was highly effective in detecting BLV in cattle
from a number of international locations. The BLV-
CoCoMo-qPCR technique amplifies a single-copy host
gene, the bovine leukocyte antigen (BoLA)-DRA gene, in
parallel with viral genomic DNA, which effectively nor-
malizes the level of viral genomic DNA. Thus, we were
able to show that the proviral load correlates not only with
the level of BLV propagation, as assessed by syncytium
formation, but also with BLV disease progression.
While the primary cellular target of BLV is B cells, re-
cent studies suggest that monocytes, granulocytes, CD2+
T cells, CD3+ T cells, CD4+ T cells, CD8+ T cells and γ/δ
T cells are also targets [4-6,20]. However, because
Mirsky et al. [5], fractionated B cells into the CD5+ IgM+
B cells and CD5- IgM+ B cell subpopulations, but did
not fractionate CD2+ T cells into the CD4+ and CD8+ T
cell subpopulations. In contrast, Wu et al. [21] isolated
the CD4+ and CD8+ T cell subpopulations, but did not
fractionate B cells into the CD5+ IgM+ B cells and CD5-
IgM+ B cell subpopulations. It remains to be clarified
the variations of the BLV proviral load among CD5+
IgM+ B cells, CD5- IgM+ B cells, CD4+ T cells, and CD8+
T cells in the same experiment. Therefore, to clarify
whether these subpopulations are susceptible to BLV in-
fection, we obtained PBMCs from cattle naturally infected
with BLV and isolated CD5+ IgM+ B cells, CD5- IgM+
B cells, CD4+ T cells, and CD8+ T cells by flow cytometry
or using magnetic beads. We then estimated the BLV pro-
viral load using the BLV-CoCoMo-qPCR technique. The
results show that CD5+ IgM+ B cells, CD5- IgM+ B cells,
CD4+ T cells, and CD8+ T cells are all primary targets for
BLV.
Methods
Animals, blood samples, sera, and DNA extraction
Blood samples were obtained from eight Holstein cows
(N790, N791, N818, N789, N787, N733, N823, and
N788) and one Japanese black cow (O10) in Japan
(Table 1). PBMCs were separated according to the
method of Miyasaka and Trunka [22]. Serum was also
obtained from the same cows. The subclinical stage of
BLV infection was evaluated according to the lympho-
cyte count (cells per μl) and the age of each cow
(≤8,500 = normal and ≥13,000 = lymphocytosis for cows
aged 2–3 years; ≤5,500 = normal and ≥7,500 = lymphocy-
tosis for cows aged ≥6 years), and by detecting atypical
mononuclear cells [23]. In the PL case, three separate
lymphocyte counts were performed at different times.
Table 1 Outline of examined BLV-infected but clinically normal cattle
Cattle Age (years) WBC (/μl) Lymphocyte (/μl) (%) Clinical stagea ELISAb Proviral loadc Syncytium assayd
(Copies/1 × 105 cells) (Number/5 × 106 cells)
BLV-free normal cattle
N790 2.5 9,540 6,382 (66.9) - - 0 0
N791 2.5 8,260 4,956 (60.0) - - 0 0
BLV-infected cattle
1) Cattle with < 100 proviral load
N818 2.0 9,410 5,147 (54.7) AL + 8 0
N789 2.5 5,472 5,472 (60.2) AL + 26 1
2) Cattle with > 100 proviral load
N787 N733 2.5 8,730 4,487 (51.4) AL + 294 250
2.5 8,230 6,313 (68.4) AL + 1,614 400
N823 2.0 9,340 6,239 (66.8) AL + 11,112 11,000
N788 2.5 9,620 5,435 (56.5) AL + 18,094 17,500
O10 15.0 12,200 7,900 (64.8) PL + 10,689 9,086
aThe clinical stage of BLV infection was evaluated according to the lymphocyte count (per 1 μl), the detection of atypical mononuclear cells, and the age of the
animal [19]. AL, BLV-infected but clinically and hematologically normal cattle; PL, BLV-infected but clinically normal cattle showing an increase in the number of
apparently normal B lymphocytes. In the latter case, three separate lymphocyte counts were performed at different times and all yielded the same results.
bELISA was performed using an anti-BLV ELISA kit according to the manufacturer’s instructions (JNC Inc., Tokyo, Japan). +, positive for anti-BLV antibodies;
-, negative for anti-BLV antibodies.
cThe proviral load (expressed as the copy number per 105 peripheral blood mononuclear cells [PBMCs]) was evaluated by BLV-CoCoMo-qPCR as previously
described [19].
dPBMCs were mixed with CC81 cells and 4 μg/ml polybrene (Sigma, St. Louis, MO) and used in the syncytium formation assay [19]. Syncytia were counted under a
light microscope.
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Guidelines for Laboratory Animal Welfare and Animal
Experiment Control set out by the Nippon Institute for
Biological Science (Permit number: 12Kenkyu-50).
Genomic DNA was isolated from EDTA-treated whole
blood samples using the Wizard Genomic DNA Purifi-
cation Kit (Promega Corporation, Tokyo, Japan) and
subsequently used for PCR.
Measurement of the BLV proviral load using BLV-
CoCoMo-qPCR
The BLV proviral load was measured using BLV-CoCoMo-
qPCR as previously described [19]. Briefly, the BLV long
terminal repeat (LTR) region was amplified using the
degenerate primer pair: CoCoMo 6 and CoCoMo 81.
FAM BLV was used as a probe. The BoLA-DRA gene
(internal control) was amplified using the primer pair,
DRA643 and DRA734. VIC-DRA was used as a probe.
ELISA
An anti-BLV antibody ELISA kit (JNC Inc., Tokyo, Japan)
was used to detect anti-BLV antibodies according to the
manufacturer’s instructions.
Syncytium formation assay
To determine the presence of BLV in the cattle, PBMCs
(5 × 106 cells/4 ml) were mixed with CC81 cells (cat cells
transformed with mouse sarcoma virus;1 × 105 cells/4 ml)and 4 μg/ml polybrene (Sigma, St. Louis, MO) in 6 cm
diameter culture dishes and used in a syncytium forma-
tion assay [19,24]. Syncytia were counted under a light
microscope after staining with May-Grunwald Giemsa.
CC81 cells were maintained in RPMI-1640 medium
supplemented with 10% heat-inactivated fetal bovine
serum (FBS), penicillin (100 U/ml), and streptomycin
(100 μg/ml).
Monoclonal antibodies (MAbs) and detection of surface
markers by flow cytometry
PBMCs were labeled using optimal concentrations of the
following MAbs: CACT105A (mouse anti-bovine CD5;
VMRD Inc., Pullman, WA); BAQ44A (mouse anti-bovine
IgM; VMRD Inc.); ILA11A (mouse anti-bovine CD4;
VMRD Inc.); or 7C2B (mouse anti-bovine CD8; VMRD
Inc.). The cells were then stained with the following
secondary fluorophore-labeled MAbs: allophycocyanin
(APC)-conjugated rat anti-mouse IgG1 (BD Pharmingen,
Tokyo, Japan) to detect CACT105A-positive cells; phyco-
erythrin (PE)-conjugated goat anti-mouse IgM (CALTAG
Laboratories, Carlsbad, CA) to detect BAQ44A-positive
cells; or PE-conjugated goat anti-mouse IgG2a (Invitrogen,
Camarillo, BD Japan) to detect ILA11A- or 7C2B-
positive cells. After staining, cells were analyzed using a
FACSCalibur™ flow cytometer (BD Japan, Tokyo, Japan)
and the data were analyzed using FCS Express (Ver. 3;
De Novo Software, Los Angeles, CA). Cells stained with
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bodies were used as a negative control.
Cell sorting
CD5+ IgM+ cells and CD5+ IgM- cells were separated from
PBMCs using a BD FACSAria™ cell sorter (BD Japan). The
purity of the sorted populations was assessed using the
same cytometer.
CD4+ and CD8+ cells were purified using the MACS®
System (Miltenyi Biotech Inc, Auburn, CA). In brief,
PBMCs were stained with ILA11A MAb (mouse anti-
bovine CD4; VMRD Inc.) or 7C2B MAb(mouse anti-
bovine CD8; VMRD Inc.) and captured by an anti-mouse
IgG MAb conjugated to magnetic beads. Magnetic bead-
bound cells were separated on an LS column. The purity of
the CD4+ and CD8+ cell populations was calculated by in-
direct immunofluorescence analysis.
Results
To estimate the BLV proviral load in cattle at the clinic-
ally normal stage of BLV infection, we obtained blood
samples from eight Holstein cows and one Japanese
black cow and analyzed them by BLV-CoCoMo-qPCR.
Two cattle were BLV-negative (N790 and N791) and seven
were BLV-positive (N818, N789, N787, N733, N823, N788
and O10) (Table 1). The same results were obtained using
the anti-BLV ELISA. The seven BLV-infected cattle were
then classified according to the EC-leukosis key [23]: Six
cattle were categorized as BLV-infected but clinically and
hematologically normal cattle, and one was categorized as
BLV-infected but clinically normal cattle with PL.
The BLV proviral load in the nucleated cells isolated
from blood samples taken from the nine cattle was ex-
amined using BLV-CoCoMo-qPCR, and the infection
capacity of BLV was assessed using the syncytium assay
(Table 1). The proviral load correlated strongly with the
syncytium count. For example, the proviral load in animals
N787, N733, N823, N788 and O10 ranged from 294 to
18,094 copies per 105 cells, and syncytium numbers
ranged from 250 to 17,500 per 5 × 106 PBMCs. Further-
more, animals N818 and N789, which had low proviral
loads (8 and 26 copies per 105 PBMCs, respectively) also
had very low syncytium counts (0 and 1 per 5 × 106
PBMCs, respectively), meaning that the sensitivity of
CoCoMo-qPCR for detecting BLV infection was greater
than that of the syncytium assay.
The percentage of CD5+ IgM+ B cells, CD5- IgM+ B
cells, CD4+ T cells, and CD8+ T cells within the PBMC
population was determined by flow cytometry (Figure 1).
Cattle with a proviral load >100 copies per 105 cells
showed an increased percentage of CD5+ IgM+ B cells
(> 10%) compared with BLV-negative cattle or cattle
with a proviral load < 100 copies per 105 cells (< 5%). In
particular, the percentage of CD5+ IgM+ B cells washigher than the percentage of CD5- IgM+ B cells in cattle
with a proviral load >100 copies per 105 cells. By contrast,
although the proportion of CD4+ T cells in cattle with a
proviral load >100 copies per 105 cells except animal O10
was similar to those in BLV-negative cattle, the proportion
of CD8+ T cells in all BLV-infected cattle was lower than
those in BLV-negative cattle.
Next, to assess the tropism of BLV for each lympho-
cyte subpopulation, animals N733, N788 and O10 (all
with a proviral load >100 copies per 105 cells) were
selected from the BLV-positive group. Animal N818 was
selected to represent cattle with a proviral load <100
copies per 105 cells because < 100 proviral load may be
the margin of sensitivity of CoCoMo-qPCR. CD5+ IgM+
B cells and CD5- IgM+ B cells were isolated by flow cy-
tometry and CD4+ T and CD8+ T cells were purified
using the MACS® System (Table 2). All cell populations
were > 90.0% pure, except for the CD8+ T cells isolated
from the blood of animal O10, which were only 75.0%
pure because of the low number of CD8+ T cells present
in this animal. Therefore, there is possibility that results
from BLV detection in CD8+ T cells from animal O10
could be due to contamination by other cell type. In all
the selected cattle, the BLV copy number was higher in
CD5+ IgM+ B cells than in the other lymphocyte popula-
tions. As shown in Table 2, CD5+ IgM+ B cells isolated
from animal N733 showed a proviral load approximately
30-fold higher than that in the other lymphocyte popula-
tions. The difference was around 3-fold in animal N788,
and around 5-fold in animal O10. Despite the fact that
animal N818 harbored a low proviral load of which lower
than the limitation of sensitivity of CoCoMo-qPCR, we
were still able to detect the BLV provirus in all four
lymphocyte populations. The copy number in CD5+ IgM+
B cells was around16-fold higher than in CD4+ T cells and
CD8+ T cells, but was similar (1.7-fold difference) to that
in CD5- IgM+ B cells.
Finally, we predicted the actual number of proviral cop-
ies per ml of peripheral blood in each of the lymphocyte
subpopulations using the following equation (Table 3):
number of proviral copies in each lymphocyte subpopulation
per ml of blood ¼ lymphocytes
μl
 
 subpopulation rateð Þ
 proviral load in each subpopulation
105
 103
BLV proviruses were mainly present in CD5+ IgM+ B
cells isolated from the three BLV-infected cattle with a
proviral load >100 copies per 105 cells (N733, N788
and O10), followed by CD4+ T cells; however, the pro-
viral loads in CD4+ cells were around 3- to 22-times









Cattle Proviral load CD5+IgM (%) CD5-IgM (%) CD4+ (%) CD8+ (%)
(copies/1 x 105 ) 
BLV-free normal cattle
N790 0 1.81 12.53 14.40 27.20
N791 0 3.11 12.37 22.59 23.68
BLV-infected cattle with < 100 proviral load
N818 8 2.96 11.81 29.37 19.34
N789 26 3.45 10.70 26.93 15.67
BLV-infected cattle with > 100 proviral load
N787 294 12.57 10.56 16.05 9.91
N733 1,614 17.60 7.78 16.53 12.20
N823 11,112 10.25 8.92 22.23 20.61
N788 18,094 19.80 16.25 16.16 18.47




BLV-infected cattle with > 100 proviral load
N790 N791
N818 N789
N787 N733 N823 N788 O10
BLV-infected cattle with < 100 proviral load
Figure 1 Flow cytometric analysis of PBMCs isolated from BLV-negative and BLV-positive cattle with proviral loads of <100 and > 100
copies per 105 cells. (A) Dual color flow cytometric analysis of PBMCs isolated from BLV-negative cattle (animals N790 and N791) and
BLV-infected cattle with proviral loads < 100 copies per 105 cells (animals N818, N789) and > 100 copies per 105 cells (animals N787, N733, N823,
N788 and N10). Each profile was separated into four quadrants on the basis of control staining (cells were incubated with normal mouse serum
and then stained with appropriate secondary antibodies), which signify single-positive [orange (574 nm) and red (660 nm)], double-negative, or
double-positive staining. The values in each gate indicate the percentage of the total PBMC population. (B) The proviral load and the percentage
of CD5+ IgM+ cells, CD5- IgM+ B cells, CD4+ T cells and CD8+ T cells in the indicated cattle.
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the proviral loads in each of these subpopulations were
different in each animal. In addition, in the case of ani-
mal with low proviral load N818 (proviral load <100
copies per 105 cells), the actual proviral copy number
in CD5- IgM+ B cells per ml blood was greater thanthat in CD5+ IgM+ B cells, CD4+ T cells, or CD8+ T
cells.
Discussion
The present study showed that the proviral load in CD5+
IgM+ B cells (which are the primary target cells for BLV
Table 2 Proviral load in the different lymphocyte
subpopulations isolated from selected BLV-infected but
clinically normal cattle.
Cattle Cell populationa Purityb (%) Proviral loadc
(Copies/105 cells)
1) BLV-infected cattle (proviral load > 100 copies/105 cells)
N733 CD5+ IgM+ 95.5 40,338
CD5- IgM+ 94.1 1,590
CD4+ 93.0 1,148
CD8+ 95.0 1,144
N788 CD5+ IgM+ 97.4 33,529
CD5- IgM+ 98.4 11,258
CD4+ 90.0 15,232
CD8+ 91.0 11,116
O10 CD5+ IgM+ 97.4 55,449
CD5- IgM+ 98.4 9,203
CD4+ 90.0 11,254
CD8+ 75.0 21,915
2) BLV-infected cattle (proviral load < 100 copies/105 cells)
N818 CD5+ IgM+ 93.3 97
CD5- IgM+ 97.6 54
CD4+ 92.3 6
CD8+ 97.1 6
aCD5+/-IgM+ cells were sorted using a flow cytometer and the MACS System
was used to sort CD4+ and CD8+ cells.
bThe purity of the CD5+/-IgM + cells was calculated using a flow cytometer
based at the Brain Sciences Institute. The purity of the CD4+ and CD8+ cells
obtained using the MACS Separation System was assessed by
immunofluorescence analysis.
cThe proviral load (expressed as the copy number per 105 cells) was estimated
using BLV-CoCoMo-qPCR [19].
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cells, or CD5- IgM+ B cells, both in terms of proviral load
per 105 cells (Table 2) and in terms of actual copy number
per ml of blood (Table 3) in all cattle with a proviral load
>100 copies per 105 cells. Interestingly, we showed that
the second most commonly infected cell in these animals










2) BLV-infected cattle (proviral load < 100 copies/105 cells)
N818 8 148
aThe proviral load in each lymphocyte subpopulation (expressed as the copy numb
calculated in terms of copies per ml.appears to infect both CD8+ T cells and CD5- IgM + B cells
to a greater extent than was reported in a previous study
[5]. The current data support the studies by Williams et al.
[20], Stott et al. [4], and Wu et al. [21] which reported that
some T cells can be infected by BLV. However, in contrast
to our results showing that CD4+ T cells are the second
most common target for BLV infection in cattle, Schwartz
et al. [6] reported that, although B cells, CD8+ T cells,
monocytes, and granulocytes were infected by BLV, CD4+
T cells were not. Moreover, Mirsky et al, used flow cytom-
etry and single-cell PCR to show that CD5+ IgM+ and
CD5- IgM+ B cells were the only PBMCs infected with
BLV in seropositive cows, either with or without PL [5].
They also suggested that peripheral CD2+ T cells, γ/δ T
cells, and monocytes are not a major reservoir for BLV in-
fection. By contrast, the present study showed that the
BLV provirus remains integrated in the DNA of CD5+
IgM+ B cells, CD5- IgM+ B cells, CD4+ T cells, and CD8+
T cells, even in animals with a proviral load <100 copies
per 105 cells of which lower than the limitation of sensitiv-
ity of CoCoMo-qPCR. Thus, we were able to use cell
sorting and BLV-CoCoMo-qPCR techniques to detect the
BLV provirus in all the lymphocyte subpopulations iso-
lated from BLV-infected, clinically normal, cattle with and
without PL. Taken together, the results show that CD5+
IgM+ B cells, CD5- IgM+ B cells, CD4+ T cells, and CD8+
T cells are all primary targets for BLV.
Thus, it appears that BLV can infect a broad spectrum
of cells, although its receptor(s) remains unknown. A pre-
vious report used the BLV envelope (ENV) receptor bind-
ing domain showed that BLV receptor molecules are
expressed by pro/pre B cells (but not by mature/arrested
B cells), by activated B and T cells (but not by arrested B
and T cells), by human thymus cells induced by IL-7, and
by proliferating lymphocytes [25]. CD4, CD8, and CD5-
IgM+ B cells proliferate in an antigen-specific manner;
however, CD5+ IgM+ B cells can proliferate in the absence
of antigen. Therefore, CD5+ IgM+ B cells may constitu-
tively express receptors for BLV, which may explain why
CD5+ IgM+ B cells harbor a high viral load.ripheral blooda) in each lymphocyte subpopulation using






er per 105 PBMCs) was estimated by BLV-CoCoMo-qPCR [19] and then
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measurements can be used to follow the dynamics of
BLV-infected cells in vivo. Mirsky and coworkers [5]
reported that the infection rate was approximately 40-fold
higher for CD5+ B cells than for CD2+ T cells (121 ± 244
for CD5+ B cells and 3 ± 6 for CD2+ T cells), suggesting
that B cells are the only PBMCs significantly infected by
BLV. However, they did not subfractionate CD2+ T cells
to CD4+ and CD8+ cells. Our result showed that CD4+
T cells harbored higher proviral copy numbers than
CD8+ and CD5-IgM+ B cells in all three cattle with a
proviral load >100 copies per 105 cells. In addition, the
data showed that the fold difference in the proviral load
in CD5+ IgM+ B cells and T cells (CD4+ T cells + CD8+
T cells) ranged from 1.5 (360,816/(133,782 + 111,587)
copies per ml) in N788 to 13 (268,914/(11,980 + 8,811)
copies per ml) in N733. This indicates that, in addition
to CD5+ IgM+ B cells, T cells are also infected with BLV.
Moreover, the syncytium assay were used for comparing
with PBMC and purified CD4+ T cell and rate of the
number of syncytium formation with 5 × 106 of PBMC
per with CD4+ T cells were almost 1.6 (data not shown).
This result suggests that CD4+ T cells could be infected
by BLV, and that BLV-infected CD4+T cells may be the
source of infectious BLV-infected cells that can then in-
fect other cells. Both the previous studies and the
present study examined the proviral load in cell popula-
tions derived from peripheral blood. It is still not known
which peripheral blood or organs maintain BLV prolif-
eration. To investigate the mechanism(s) underlying
BLV proliferation in vivo, it will be necessary to analyze
the proviral load in key organs and in peripheral blood.
Conclusions
To clarify which subpopulations of lymphocytes were
infected by BLV at subclinical stage, we used the BLV-
CoCoMo-qPCR method, which enabled us to demonstrate
that proviral load correlates not only with BLV infection
capacity, as assessed by syncytium formation, but also with
BLV disease progression. This study shows that, while
CD5+ IgM+ B cells harbor the greatest BLV proviral load
during the subclinical stage of EBL, CD4+ T cells and CD8+
T cells are also primary targets for BLV. Taken together,
the results of this study show that the tropism of BLV is
wider than previously thought.
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